Clinical score can guide PRRT therapy decisions for neuroendocrine tumors
Peptide receptor radionuclide therapy (PRRT) with lutetium dotatate is a treatment for well-differentiated neuroendocrine tumors that the U.S. Food
Source: miragenews.com
Stay updated with breaking news from Marques Bradshaw. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Peptide receptor radionuclide therapy (PRRT) with lutetium dotatate is a treatment for well-differentiated neuroendocrine tumors that the U.S. Food